Publication | Open Access
Gefitinib Therapy in Advanced Bronchioloalveolar Carcinoma: Southwest Oncology Group Study S0126
153
Citations
19
References
2006
Year
Gefitinib is an active agent in advanced stage BAC. Several subsets demonstrate significantly improved clinical outcomes.
| Year | Citations | |
|---|---|---|
Page 1
Page 1